Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report sent to investors on Saturday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE opened at $0.00 on Friday. The stock’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.02. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $2.47. The firm has a market capitalization of $2,964.00, a price-to-earnings ratio of 0.00 and a beta of 3.71.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.